ALLISON KAVANAGH: Open Payments
NPI 1073260469 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 20 payments from 6 companies in 2025. Trend: 2023 $339 · 2024 $197 · 2025 $681
Food & beverage: $596Education: $85
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $186 |
| GENZYME CORPORATION | 8 | $159 |
| Madrigal Pharmaceuticals | 1 | $150 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $45 |
Products named: DUPIXENT, REZDIFFRA, AIRSUPRA, NEFFY, TEZSPIRE, NUCALA, BREZTRI.
Industry payments across AZ — which companies pay providers there.
